MAHLY

MediPal Holdings Corporation MAHLY

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MAHLY ALFRY WLCGF CSMYF SHWGF SDGCF BUGDF AMFPF SNPHY BUHPF
6M 0.50 % 19.23 % 0.00 % 0.00 % 0.00 % 0.00 % -32.96 % -6.95 % 2.02 % 0.00 %
YTD 0.81 % 19.23 % 0.00 % -6.42 % 13.43 % 0.00 % -32.96 % -32.00 % -0.39 % -42.26 %
1Y -11.18 % 19.23 % 0.00 % 17.20 % -20.83 % 0.00 % -46.52 % -38.16 % -18.06 % -42.26 %
3Y 23.08 % 19.23 % -22.59 % -6.31 % -37.70 % 15.49 % -27.19 % -30.12 % 51.95 % -15.65 %
5Y -12.61 % -31.48 % -51.35 % -6.31 % -68.98 % -27.84 % 25.15 % -46.42 % -48.55 % 25.65 %
10Y -3.28 % -31.48 % -51.35 % -6.31 % 7.04 % 7.80 % -25.92 % 128.13 % -25.81 % -25.38 %
From the beginning 38.90 % -31.48 % -51.35 % -6.31 % -69.23 % 28.68 % 267.83 % -21.60 % -24.44 % 870.00 %

Dividend

MediPal Holdings Corporation

Alfresa Holdings Corporation

Welcia Holdings Co., Ltd.

COSMOS Pharmaceutical Corporation

Shandong Weigao Group Medical Polymer Company Limited

Sundrug Co.,Ltd.

Bumrungrad Hospital Public Company Limited

Amplifon S.p.A.

Santen Pharmaceutical Co., Ltd.

Bumrungrad Hospital Public Company Limited